| Filed On | Filing |
|---|---|
| 22 Oct 2026 | Form 3: Touami Sofia, Chief Business Officer |
| 22 Oct 2026 |
Form 3: Staben Steven, Chief Scientific Officer
Holds 55,448 shares of Common Stock |
| 22 Oct 2026 | Form 3: Bachrodt Amy, Chief Financial Officer |
| 22 Oct 2026 | Form 3: Lee Chin Hyok, Chief Medical Officer |
| 22 Oct 2026 |
Form 3: Trombley Aetna Wun, Director
Holds 415,255 shares of Common Stock |
| 22 Oct 2026 |
Form 3: Bertozzi Carolyn R, 10% owner
Holds 904,821 shares of Common Stock |
| 22 Oct 2026 | Form 3: Henderson Jane, Director |
| 22 Oct 2026 |
Form 3: Fischer Laurent, Director
Holds 33,269 shares of Common Stock |
| 22 Oct 2026 | Form 3: Venrock Healthcare Capital Partners III, L.p., 10% owner and 8 others |
| 22 Oct 2026 |
Form 3: Eli Lilly & Co, 10% owner
Holds 1,104,558 shares of Common Stock |
| 22 Oct 2026 | Form 3: Versant Ventures Vii GP, L.p., 10% owner and 5 others |
| 22 Oct 2026 |
Form 3: Rieflin William Jl, Director
Holds 89,781 shares of Common Stock |
Loading...